Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Sell
37
DGX Quote, Financials, Valuation and Earnings
Last price:
$174.47
Seasonality move
:
3.05%
Day range:
$174.43 - $178.30
52-week range:
$148.70 - $197.55
Dividend yield:
1.81%
P/E ratio:
20.47x
P/S ratio:
1.82x
P/B ratio:
2.67x
Volume:
942.4K
Avg. volume:
896.9K
1-year change:
13.25%
Market cap:
$19.4B
Revenue:
$9.9B
EPS (TTM):
$8.52
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
DGX
Quest Diagnostics, Inc.
|
$2.8B | $2.36 | 5.05% | 21.08% | $198.06 |
|
DHR
Danaher Corp.
|
$6.8B | $2.14 | 3.79% | 43.39% | $261.05 |
|
EXAS
EXACT Sciences Corp.
|
$860.7M | $0.08 | 17.71% | -84.17% | $104.56 |
|
GH
Guardant Health, Inc.
|
$267.7M | -$0.47 | 32.68% | -47.37% | $119.09 |
|
LH
Labcorp Holdings, Inc.
|
$3.6B | $3.93 | 6.94% | 131.26% | $299.71 |
|
WGS
GeneDx Holdings Corp.
|
$120.5M | $0.10 | 25.98% | -44.8% | $170.89 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
DGX
Quest Diagnostics, Inc.
|
$174.44 | $198.06 | $19.4B | 20.47x | $0.80 | 1.81% | 1.82x |
|
DHR
Danaher Corp.
|
$238.37 | $261.05 | $168.4B | 49.06x | $0.32 | 0.54% | 7.08x |
|
EXAS
EXACT Sciences Corp.
|
$102.11 | $104.56 | $19.3B | -- | $0.00 | 0% | 6.21x |
|
GH
Guardant Health, Inc.
|
$110.17 | $119.09 | $14.3B | -- | $0.00 | 0% | 15.15x |
|
LH
Labcorp Holdings, Inc.
|
$254.67 | $299.71 | $21.1B | 25.01x | $0.72 | 1.13% | 1.55x |
|
WGS
GeneDx Holdings Corp.
|
$137.47 | $170.89 | $4B | 2,279.77x | $0.00 | 0% | 9.80x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
DGX
Quest Diagnostics, Inc.
|
46.79% | 0.042 | 30.05% | 0.90x |
|
DHR
Danaher Corp.
|
26.23% | 0.141 | 12.96% | 0.85x |
|
EXAS
EXACT Sciences Corp.
|
50.33% | 1.440 | 24.46% | 2.24x |
|
GH
Guardant Health, Inc.
|
136.47% | 1.336 | 16.98% | 2.94x |
|
LH
Labcorp Holdings, Inc.
|
42.88% | 0.845 | 27.39% | 1.10x |
|
WGS
GeneDx Holdings Corp.
|
28.13% | 1.811 | 3.68% | 2.47x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
DGX
Quest Diagnostics, Inc.
|
$911M | $420M | 7.41% | 14.33% | 14.92% | $419M |
|
DHR
Danaher Corp.
|
$3.6B | $1.3B | 5.07% | 6.87% | 20.73% | $1.4B |
|
EXAS
EXACT Sciences Corp.
|
$583.9M | $16.3M | -18.87% | -38% | 1.91% | $190M |
|
GH
Guardant Health, Inc.
|
$171.6M | -$99M | -36.05% | -8518.58% | -37.33% | -$45.8M |
|
LH
Labcorp Holdings, Inc.
|
$955.6M | $403.2M | 5.61% | 10.25% | 11.32% | $280.5M |
|
WGS
GeneDx Holdings Corp.
|
$79.4M | -$3.1M | 0.56% | 0.82% | -2.68% | $9.6M |
Quest Diagnostics, Inc. vs. Competitors
-
Which has Higher Returns DGX or DHR?
Danaher Corp. has a net margin of 9.13% compared to Quest Diagnostics, Inc.'s net margin of 15%. Quest Diagnostics, Inc.'s return on equity of 14.33% beat Danaher Corp.'s return on equity of 6.87%.
Company Gross Margin Earnings Per Share Invested Capital DGXQuest Diagnostics, Inc.32.35% $2.15 $13.8B DHRDanaher Corp.59.87% $1.27 $69.2B -
What do Analysts Say About DGX or DHR?
Quest Diagnostics, Inc. has a consensus price target of $198.06, signalling upside risk potential of 13.54%. On the other hand Danaher Corp. has an analysts' consensus of $261.05 which suggests that it could grow by 9.51%. Given that Quest Diagnostics, Inc. has higher upside potential than Danaher Corp., analysts believe Quest Diagnostics, Inc. is more attractive than Danaher Corp..
Company Buy Ratings Hold Ratings Sell Ratings DGXQuest Diagnostics, Inc.7 10 0 DHRDanaher Corp.18 3 0 -
Is DGX or DHR More Risky?
Quest Diagnostics, Inc. has a beta of 0.642, which suggesting that the stock is 35.788% less volatile than S&P 500. In comparison Danaher Corp. has a beta of 0.899, suggesting its less volatile than the S&P 500 by 10.093%.
-
Which is a Better Dividend Stock DGX or DHR?
Quest Diagnostics, Inc. has a quarterly dividend of $0.80 per share corresponding to a yield of 1.81%. Danaher Corp. offers a yield of 0.54% to investors and pays a quarterly dividend of $0.32 per share. Quest Diagnostics, Inc. pays 39.15% of its earnings as a dividend. Danaher Corp. pays out 20.42% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DGX or DHR?
Quest Diagnostics, Inc. quarterly revenues are $2.8B, which are smaller than Danaher Corp. quarterly revenues of $6.1B. Quest Diagnostics, Inc.'s net income of $257M is lower than Danaher Corp.'s net income of $908M. Notably, Quest Diagnostics, Inc.'s price-to-earnings ratio is 20.47x while Danaher Corp.'s PE ratio is 49.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quest Diagnostics, Inc. is 1.82x versus 7.08x for Danaher Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DGXQuest Diagnostics, Inc.1.82x 20.47x $2.8B $257M DHRDanaher Corp.7.08x 49.06x $6.1B $908M
-
Which has Higher Returns DGX or EXAS?
EXACT Sciences Corp. has a net margin of 9.13% compared to Quest Diagnostics, Inc.'s net margin of -2.3%. Quest Diagnostics, Inc.'s return on equity of 14.33% beat EXACT Sciences Corp.'s return on equity of -38%.
Company Gross Margin Earnings Per Share Invested Capital DGXQuest Diagnostics, Inc.32.35% $2.15 $13.8B EXASEXACT Sciences Corp.68.64% -$0.10 $5B -
What do Analysts Say About DGX or EXAS?
Quest Diagnostics, Inc. has a consensus price target of $198.06, signalling upside risk potential of 13.54%. On the other hand EXACT Sciences Corp. has an analysts' consensus of $104.56 which suggests that it could grow by 2.4%. Given that Quest Diagnostics, Inc. has higher upside potential than EXACT Sciences Corp., analysts believe Quest Diagnostics, Inc. is more attractive than EXACT Sciences Corp..
Company Buy Ratings Hold Ratings Sell Ratings DGXQuest Diagnostics, Inc.7 10 0 EXASEXACT Sciences Corp.3 18 0 -
Is DGX or EXAS More Risky?
Quest Diagnostics, Inc. has a beta of 0.642, which suggesting that the stock is 35.788% less volatile than S&P 500. In comparison EXACT Sciences Corp. has a beta of 1.404, suggesting its more volatile than the S&P 500 by 40.386%.
-
Which is a Better Dividend Stock DGX or EXAS?
Quest Diagnostics, Inc. has a quarterly dividend of $0.80 per share corresponding to a yield of 1.81%. EXACT Sciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quest Diagnostics, Inc. pays 39.15% of its earnings as a dividend. EXACT Sciences Corp. pays out -- of its earnings as a dividend. Quest Diagnostics, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DGX or EXAS?
Quest Diagnostics, Inc. quarterly revenues are $2.8B, which are larger than EXACT Sciences Corp. quarterly revenues of $850.7M. Quest Diagnostics, Inc.'s net income of $257M is higher than EXACT Sciences Corp.'s net income of -$19.6M. Notably, Quest Diagnostics, Inc.'s price-to-earnings ratio is 20.47x while EXACT Sciences Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quest Diagnostics, Inc. is 1.82x versus 6.21x for EXACT Sciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DGXQuest Diagnostics, Inc.1.82x 20.47x $2.8B $257M EXASEXACT Sciences Corp.6.21x -- $850.7M -$19.6M
-
Which has Higher Returns DGX or GH?
Guardant Health, Inc. has a net margin of 9.13% compared to Quest Diagnostics, Inc.'s net margin of -34.97%. Quest Diagnostics, Inc.'s return on equity of 14.33% beat Guardant Health, Inc.'s return on equity of -8518.58%.
Company Gross Margin Earnings Per Share Invested Capital DGXQuest Diagnostics, Inc.32.35% $2.15 $13.8B GHGuardant Health, Inc.64.71% -$0.74 $971.9M -
What do Analysts Say About DGX or GH?
Quest Diagnostics, Inc. has a consensus price target of $198.06, signalling upside risk potential of 13.54%. On the other hand Guardant Health, Inc. has an analysts' consensus of $119.09 which suggests that it could grow by 8.1%. Given that Quest Diagnostics, Inc. has higher upside potential than Guardant Health, Inc., analysts believe Quest Diagnostics, Inc. is more attractive than Guardant Health, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DGXQuest Diagnostics, Inc.7 10 0 GHGuardant Health, Inc.16 1 0 -
Is DGX or GH More Risky?
Quest Diagnostics, Inc. has a beta of 0.642, which suggesting that the stock is 35.788% less volatile than S&P 500. In comparison Guardant Health, Inc. has a beta of 1.584, suggesting its more volatile than the S&P 500 by 58.44%.
-
Which is a Better Dividend Stock DGX or GH?
Quest Diagnostics, Inc. has a quarterly dividend of $0.80 per share corresponding to a yield of 1.81%. Guardant Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quest Diagnostics, Inc. pays 39.15% of its earnings as a dividend. Guardant Health, Inc. pays out -- of its earnings as a dividend. Quest Diagnostics, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DGX or GH?
Quest Diagnostics, Inc. quarterly revenues are $2.8B, which are larger than Guardant Health, Inc. quarterly revenues of $265.2M. Quest Diagnostics, Inc.'s net income of $257M is higher than Guardant Health, Inc.'s net income of -$92.7M. Notably, Quest Diagnostics, Inc.'s price-to-earnings ratio is 20.47x while Guardant Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quest Diagnostics, Inc. is 1.82x versus 15.15x for Guardant Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DGXQuest Diagnostics, Inc.1.82x 20.47x $2.8B $257M GHGuardant Health, Inc.15.15x -- $265.2M -$92.7M
-
Which has Higher Returns DGX or LH?
Labcorp Holdings, Inc. has a net margin of 9.13% compared to Quest Diagnostics, Inc.'s net margin of 7.34%. Quest Diagnostics, Inc.'s return on equity of 14.33% beat Labcorp Holdings, Inc.'s return on equity of 10.25%.
Company Gross Margin Earnings Per Share Invested Capital DGXQuest Diagnostics, Inc.32.35% $2.15 $13.8B LHLabcorp Holdings, Inc.26.82% $3.12 $15.2B -
What do Analysts Say About DGX or LH?
Quest Diagnostics, Inc. has a consensus price target of $198.06, signalling upside risk potential of 13.54%. On the other hand Labcorp Holdings, Inc. has an analysts' consensus of $299.71 which suggests that it could grow by 17.68%. Given that Labcorp Holdings, Inc. has higher upside potential than Quest Diagnostics, Inc., analysts believe Labcorp Holdings, Inc. is more attractive than Quest Diagnostics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DGXQuest Diagnostics, Inc.7 10 0 LHLabcorp Holdings, Inc.12 5 0 -
Is DGX or LH More Risky?
Quest Diagnostics, Inc. has a beta of 0.642, which suggesting that the stock is 35.788% less volatile than S&P 500. In comparison Labcorp Holdings, Inc. has a beta of 0.999, suggesting its less volatile than the S&P 500 by 0.053000000000003%.
-
Which is a Better Dividend Stock DGX or LH?
Quest Diagnostics, Inc. has a quarterly dividend of $0.80 per share corresponding to a yield of 1.81%. Labcorp Holdings, Inc. offers a yield of 1.13% to investors and pays a quarterly dividend of $0.72 per share. Quest Diagnostics, Inc. pays 39.15% of its earnings as a dividend. Labcorp Holdings, Inc. pays out 32.58% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DGX or LH?
Quest Diagnostics, Inc. quarterly revenues are $2.8B, which are smaller than Labcorp Holdings, Inc. quarterly revenues of $3.6B. Quest Diagnostics, Inc.'s net income of $257M is lower than Labcorp Holdings, Inc.'s net income of $261.5M. Notably, Quest Diagnostics, Inc.'s price-to-earnings ratio is 20.47x while Labcorp Holdings, Inc.'s PE ratio is 25.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quest Diagnostics, Inc. is 1.82x versus 1.55x for Labcorp Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DGXQuest Diagnostics, Inc.1.82x 20.47x $2.8B $257M LHLabcorp Holdings, Inc.1.55x 25.01x $3.6B $261.5M
-
Which has Higher Returns DGX or WGS?
GeneDx Holdings Corp. has a net margin of 9.13% compared to Quest Diagnostics, Inc.'s net margin of -6.54%. Quest Diagnostics, Inc.'s return on equity of 14.33% beat GeneDx Holdings Corp.'s return on equity of 0.82%.
Company Gross Margin Earnings Per Share Invested Capital DGXQuest Diagnostics, Inc.32.35% $2.15 $13.8B WGSGeneDx Holdings Corp.68.04% -$0.27 $406.6M -
What do Analysts Say About DGX or WGS?
Quest Diagnostics, Inc. has a consensus price target of $198.06, signalling upside risk potential of 13.54%. On the other hand GeneDx Holdings Corp. has an analysts' consensus of $170.89 which suggests that it could grow by 24.31%. Given that GeneDx Holdings Corp. has higher upside potential than Quest Diagnostics, Inc., analysts believe GeneDx Holdings Corp. is more attractive than Quest Diagnostics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DGXQuest Diagnostics, Inc.7 10 0 WGSGeneDx Holdings Corp.6 1 0 -
Is DGX or WGS More Risky?
Quest Diagnostics, Inc. has a beta of 0.642, which suggesting that the stock is 35.788% less volatile than S&P 500. In comparison GeneDx Holdings Corp. has a beta of 2.053, suggesting its more volatile than the S&P 500 by 105.339%.
-
Which is a Better Dividend Stock DGX or WGS?
Quest Diagnostics, Inc. has a quarterly dividend of $0.80 per share corresponding to a yield of 1.81%. GeneDx Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quest Diagnostics, Inc. pays 39.15% of its earnings as a dividend. GeneDx Holdings Corp. pays out -- of its earnings as a dividend. Quest Diagnostics, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DGX or WGS?
Quest Diagnostics, Inc. quarterly revenues are $2.8B, which are larger than GeneDx Holdings Corp. quarterly revenues of $116.7M. Quest Diagnostics, Inc.'s net income of $257M is higher than GeneDx Holdings Corp.'s net income of -$7.6M. Notably, Quest Diagnostics, Inc.'s price-to-earnings ratio is 20.47x while GeneDx Holdings Corp.'s PE ratio is 2,279.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quest Diagnostics, Inc. is 1.82x versus 9.80x for GeneDx Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DGXQuest Diagnostics, Inc.1.82x 20.47x $2.8B $257M WGSGeneDx Holdings Corp.9.80x 2,279.77x $116.7M -$7.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
65
RGC alert for Jan 10
Regencell Bioscience Holdings Ltd. [RGC] is up 10.55% over the past day.
Sell
50
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
